Company intelligence / Profile preview

Troponwerke

Cologne, North Rhine-Westphalia, Germany
Ownership
Private
Development stage
Other
01

Overview

Troponwerke was a German pharmaceutical company based in Cologne, founded in 1898 by Gottfried Hagen. The company initially achieved international success with 'Tropon,' a high-purity protein powder derived from animal and vegetable sources used as a nutritional supplement. Over the decades, Troponwerke transitioned into a research-oriented pharmaceutical firm, becoming particularly well-known for its portfolio in psychiatry and neurology. Its most significant pharmaceutical contribution was the development and marketing of the neuroleptic drug melperone, sold under the brand name Eunerpan. The company was acquired by Bayer in 1967 and operated as a subsidiary for several decades. It was eventually fully integrated into Bayer's pharmaceutical division in the late 1990s, and its independent legal existence ceased in the early 2000s.

Therapeutic areas
NeurologyPsychiatryMetabolic Disorders
Modalities
Small moleculeProteinBiologicBotanical extract
Industry
Biotech

Beyond the preview

Go deeper on Troponwerke.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Troponwerke.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call